News

Vancouver, Canada, April 11, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce new assay results from contiguous rock-chip sampling from the Limarinho South zone at its Boticas gold project in Portugal, which include a highlight of 6.0m @ 5.7 g/t Au. Significantly, infill grid-soil sampling over the entire Limarinho Zone has identified two new gold anomalies, increasing the anomalous area to 4km by 2km. The Limarinho South zone, is located approximately 500m south of the main Limarinho Zone. The newly mapped gold mineralization and associated[…]

Vancouver, Canada, March 24, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) announces that it has completed its previously announced CAD$100,000 short-term loan transaction which will provide funding for general working capital requirements. The loan is repayable within six months and bears interest at 8% per annum. In consideration for the loan, Medgold has issued to the lender warrants to purchase up to 500,000 common shares of Medgold exercisable for one year at $0.09 per share. Any common shares acquired on exercise of the warrants will be subject to[…]

Vancouver, Canada, March 15, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) announces that it has arranged an arm’s length CAD$100,000 short-term loan to provide funding for general working capital requirements. The loan is repayable within six months and bears interest at 8% per annum. In consideration for the loan, Medgold has agreed, subject to stock exchange approval, to issue to the lender warrants to purchase up to 500,000 common shares of Medgold exercisable for one year at $0.09 per share. About Medgold Medgold is a European-focused, TSX-V listed[…]

Vancouver, Canada, February 22, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce that recent exploration of a new prospect called Guimarei on the Valongo licence in northern Portugal, has identified anomalous gold in rocks outcropping over a 3 km strike length. Assay results from rock chip sampling range from trace gold to highlights of 7.80 g/t Au, 4.84 g/t Au and 2.53 g/t Au. Dan James, President of Medgold, said: “Guimarei is a brand new gold discovery by Medgold. We’ve picked up gold mineralization[…]

Vancouver, Canada, January 20, 2016, Medgold Resources Corp. (TSX-V: MED) (the “Company” or “Medgold”) is pleased to announce it has established a wholly-owned subsidiary in the Republic of Serbia, and has subsequently applied for a 100 sq. km exploration licence targeting newly identified epithermal-porphyry mineralization in the country. Dan James, the President of Medgold, said: “We’re excited to establish ourselves in Serbia which has a long and rich history and culture of mining. The country has a tremendous metal endowment and Serbia’s mining industry enjoys high-level government support. Our decision[…]